Overview

Single Dose of Lu AF28996 to Healthy Young Men

Status:
Completed
Trial end date:
2019-08-21
Target enrollment:
0
Participant gender:
Male
Summary
This study evaluates how increasing doses of Lu AF28996 enters, moves through and exits the body when given by mouth to healthy young men.
Phase:
Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
H. Lundbeck A/S
Criteria
Inclusion Criterium:

Healthy, young, non-smoking men aged ≥18 and ≤45 years and with a body mass index (BMI)
≥18.5kg/m2 and ≤30kg/m2 at the Screening Visit

Other in- and exclusion criteria may apply